Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call pertaining to the Unaudited Financial Results for quarter and half year ended Se...

Proven Ability In Life Sciences

November 14, 2022

To, BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

National Stock Exchange of India Limited Listing Department Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051

Scrip code: 512529

Symbol: SEQUENT

Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Earnings Call Transcript for the quarter and half year ended September 30, 2022

Dear Sir/ Madam,

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and

Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript

pertaining to the Unaudited Financial Results of the Company for quarter and half year ended

September 30, 2022.

The same is also available on the Company’s website at SeQuentScientific-Earnings-08Nov-

2022.pdf

Kindly take the same on your records.

Yours faithfully,

For Sequent Scientific Limited

Krunal Shah Company Secretary & Compliance Officer

Registered Office: 301, 3rd Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra, India Tel No.: +91-22-4111-4777 I CIN: L99999MH1985PLC036685 Website: http://www.sequent.in I Email Id: investorrelations@sequent.in

SeQuent Scientific Limited